SCHEMBL27226470

SCHEMBL27226470

N#Cc1nccc(N2CC3(CCNCC3)C2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.54
▸ HSD17B10 Q99714 7/20 0.54
▸ CYP1A2 P05177 5/20 0.54
▸ HPGD P15428 4/20 0.54
▸ CYP2D6 P10635 8/20 0.42
▸ TSHR P16473 6/20 0.42
▸ CYP3A4 P08684 5/20 0.42
▸ USP2 O75604 4/20 0.42
▸ CYP2C9 P11712 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ RET P07949 1/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.39
▸ TP53 P04637 2/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38
▸ CTSS P25774 4/20 0.38
▸ HRH4 Q9H3N8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27226710 0.86 HRH3 (0.46) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL30815290 0.81 HRH3 (0.59) ALDH1A1HSD17B10CYP1A2CYP3A4USP2
SCHEMBL27226644 0.81 HRH3 (0.59) ALDH1A1HSD17B10CYP1A2CYP3A4USP2
SCHEMBL13018665 0.78 HRH3 (0.65) ALDH1A1HSD17B10CYP1A2HPGDCYP2D6
SCHEMBL27227185 0.78 HRH3 (0.64) ALDH1A1HSD17B10CYP1A2HPGDCYP2D6
SCHEMBL27311244 0.78 GPR119 (0.38) HRH3GPR119CTSS
SCHEMBL16430513 0.74 ALDH1A1 (0.56) ALDH1A1HSD17B10CYP1A2HPGDCYP2D6
SCHEMBL15998288 0.72 GPR119 (0.50) ALDH1A1HSD17B10MAPK1SMN1; SMN2HRH3
SCHEMBL31544804 0.72 GPR119 (0.70) ALDH1A1HSD17B10HPGDCYP2D6TSHR
SCHEMBL29946786 0.72 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP1A2HPGDCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 — — EP disclosed
US-20250092040-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. 2025-03-20 — — US disclosed
US-20240239797-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. 2024-07-18 — — US disclosed
US-11999730-B1 AKT1 modulators ALTEROME THERAPEUTICS, INC. (US) 2024-06-04 — — US disclosed
US-20240174667-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. 2024-05-30 — — US disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239797-A1 AKT1 MODULATORS AKT1S1, AKT1, AKT2 ALDH1A1 4692/4885HSD17B10 1835/4885CYP1A2 4794/4885
US-20250092040-A1 AKT1 MODULATORS AKT1S1, AKT1, AKT2 ALDH1A1 4692/4885HSD17B10 1835/4885CYP1A2 4794/4885
US-11999730-B1 AKT1 modulators AKT1S1, AKT1, AKT2 ALDH1A1 4692/4885HSD17B10 1835/4885CYP1A2 4794/4885
US-20240174667-A1 AKT1 MODULATORS AKT1S1, AKT1, AKT2 ALDH1A1 4692/4885HSD17B10 1835/4885CYP1A2 4794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback